Synchrony Financial vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 83)

Synchrony Financial

LeaderConsumer Finance

Consumer Credit

Synchrony Financial (SYF) reported ~$15.9B revenue in FY2024. America's largest provider of private-label credit cards, partnering with major retailers, healthcare, and home goods brands. HQ: Stamford, CT.

AI VisibilityBeta
Overall Score
A83
Category Rank
#1 of 1
AI Consensus
57%
Trend
stable
Per Platform
ChatGPT
93
Perplexity
87
Gemini
81

About

Synchrony Financial is the largest provider of private-label credit cards in the United States, offering financing solutions to consumers through partnerships with over 1,500 retailers, healthcare providers, and other merchants. Spun off from GE Capital in 2014, Synchrony operates a unique "dual card" model where it issues both store-branded (private-label) and co-branded (Visa/Mastercard) credit cards on behalf of partners including PayPal, Amazon, Lowe's, Gap, Ashley Furniture, and CareCredit (healthcare financing). Consumers use these cards primarily at their respective partner merchants.

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

83
Overall Score
90
#1
Category Rank
#83
57
AI Consensus
58
stable
Trend
stable
93
ChatGPT
84
87
Perplexity
97
81
Gemini
99
74
Claude
86
83
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.